Welcome to San Francisco Biotech Networks DAILY for 01/11/2026. Daily news and jobs are listed below. Please forward this email to your colleagues so they can subscribe at biotechnetworks.org/daily

​​​​​​​

Click a link below to view the mailing archive as if it had been sent to you.

2021-06-30 01:30This small biotech is working on an oral Covid antiviral drug. It just agreed to a SPAC merger. and more...
2021-06-29 01:30Adicet Bio Added to the Russell 2000® Index and more...
2021-06-28 01:30Innovent Announces the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with BYVASDA® (bevacizumab biosimilar injection) as First-Line Therapy for People with Hepatocellular Carcinoma
2021-06-27 01:30Akero Therapeutics Presents at the American Diabetes Association’s 81st Scientific Sessions, Demonstrating that Improvements in Adipose Tissue Metabolism Contributed Substantially to Improved Liver Health and Better Glycemic Control in ...
2021-06-26 01:30Berkeley student innovation teams offer 6 ideas to improve disaster response and more...
2021-06-25 01:30Graphite Bio Announces Pricing of Upsized Initial Public Offering and more...
2021-06-24 01:30Octave set out to end the wait for therapy. Then it got its own waitlist. and more...
2021-06-23 01:30Sintilimab in Combination with Chemotherapy Meets Overall Survival Primary Endpoint in the Global Phase 3 ORIENT-15 Study for the First-Line Treatment of Esophageal Squamous Cell Carcinoma and more...
2021-06-22 01:30Industry Leaders Join 23andMe Board of Directors and more...
2021-06-21 01:30Study Results of Sintilimab in Combination with Bevacizumab Biosimilar IBI305 for the First-Line Treatment of Hepatocellular Carcinoma Published in The Lancet Oncology
2021-06-19 01:30CORRECTING and REPLACING Guardant Health Presents Data at 2021 ASCO Annual Meeting Showing Utility of Liquid Biopsy in Early- and Late-Stage Cancers and more...
2021-06-18 01:30Innovent Announces First Patient Dosed in the Phase II Basket Trial of Taletrectinib for Solid Tumors with NTRK Fusion and more...
2021-06-17 01:30Pamrevlumab Included in Pancreatic Cancer Action Network’s Adaptive Clinical Trial Platform and more...
2021-06-16 01:30Protagonist Therapeutics Announces Pricing of $115 Million Upsized Public Offering of Common Stock and more...
2021-06-15 01:30BioCardia to Be Added to the Russell Microcap® Index and more...
2021-06-14 01:30RAPT Therapeutics to Report Top Line Data from Phase 1b Trial of RPT193 in Atopic Dermatitis
2021-06-13 01:30Longer-term Data for Kite’s Yescarta® in Relapsed or Refractory Follicular Lymphoma Demonstrate Substantial Survival Improvement Over Current Therapies in Comparative Analysis
2021-06-12 01:30How digital health is making UCSF's lung transplant program more accessible and more...
2021-06-11 01:30A Stanford lab's drug could be Covid's worst enemy and key to this company's IPO and more...
2021-06-10 01:30Dynavax to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and more...
2021-06-09 01:30Global Microplate Systems Market to Reach $1.1 Billion by 2026 and more...
2021-06-08 01:30Space Travel Weakens Our Immune Systems – Now Scientists May Know Why and more...
2021-06-07 01:30Innovent Releases Phase 1 Results of Pemigatinib in Chinese Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021 and more...
2021-06-05 01:30As $8 billion Illumina deal awaits antitrust greenlight, Grail launches flagship cancer test and more...
2021-06-04 01:30Clinical Trial Results of the BCMA CAR-T Co-developed by IASO Biotherapeutics and Innovent Commented in American Society of Hematology’s Medical Journal, Blood and more...
2021-06-03 01:30Clinical Trial Results of the BCMA CAR-T Co-developed by Innovent and IASO Biotherapeutics Commented in American Society of Hematology's Medical Journal "Blood" and more...
2021-06-02 01:30Inside a Big Pharma cancer drug approval with roots in a small Bay Area biotech and more...
2021-06-01 01:30Innovent Biologics and AnHeart Therapeutics Jointly Announce Exclusive License Agreement for Taletrectinib in Greater China

 

<< Archive Index • Subscribe >>

 

© Biotech Networks. You're receiving this email because you've signed up to receive updates from us.

If you'd prefer not to receive updates, you can unsubscribe.
 
© FeedBlitz® - Win the Inbox ™ | feedblitz.com | info@feedblitz.com | Privacy | Terms of Service
 English | Português | Français | Español | Italiano | Nederlands | Svenska | Deutsch | 日本語